Press Releases Keyword Search Year None20222021202020192018 May 16, 2022 CRISPR Therapeutics Announces the Appointment of Phuong Khanh Morrow, M.D., FACP, as Chief Medical Officer May 12, 2022 CRISPR Therapeutics Announces Oral Presentation of New Clinical Data on Anti-CD70 Allogeneic CAR-T Therapy CTX130™ for Patients with T-cell Lymphoma at the Annual European Hematology Association (EHA) 2022 Hybrid Congress May 09, 2022 CRISPR Therapeutics Provides Business Update and Reports First Quarter 2022 Financial Results May 04, 2022 CRISPR Therapeutics to Present at the 2022 Bank of America Healthcare Conference Apr 12, 2022 CRISPR Therapeutics Proposes New Appointment to the Board of Directors Apr 07, 2022 CRISPR Therapeutics to Participate in Upcoming Investor Conferences Mar 08, 2022 CRISPR Therapeutics Announces Poster Presentation at the American Association for Cancer Research 2022 Annual Meeting Feb 28, 2022 CRISPR Therapeutics to Participate in Upcoming Investor Conferences Feb 15, 2022 CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results Feb 09, 2022 CRISPR Therapeutics to Participate in the 11th Annual SVB Leerink Global Healthcare Conference Feb 02, 2022 CRISPR Therapeutics and ViaCyte, Inc. Announce First Patient Dosed in Phase 1 Clinical Trial of Novel Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes (T1D)